Detall de la convocatòria

Característiques

Característica
Característiques principals
WADA invites researchers, with expertise in the field of hematology, to apply for funding to undertake research projects aimed at delivering an anti-doping method that detects autologous blood transfusion (ABT).
At a minimum, the method should:
  • be applicable for blood and/or urine;
  • be sensitive enough to detect ABT in a proportion of less than 150 mL (or 4%) of transfused, refrigerated or frozen, red blood cells (RBCs) with a window of detection of at least 24/36 hours;
  • have a degree of specificity of 99.99% or above; and
  • be transferrable to WADA-accredited laboratories for routine anti-doping testing.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.1670
    Marta López: [email protected], Ext.: 1576
    Convocatòria (URL)
    https://wada-main-prod.s3.amazonaws.com/wada-science-call-for-research-proposals-abt-final-en.pdf
    Informació addicional
    Les sol·licituds es presenten mitjançant el sistema electrònic WADAGrants a:
    https://grants.wada-ama.org/science/home?l=en
    Dotació
    The Agency anticipates funding two to three grants for the initial proof of concept phase.
    The funding would be up to:
  • USD 300,000 per project for initial proof of concept
  • USD 300,000 for validation of proof of concept
  • USD 200,000 for transfer to accredited laboratories
  • USD 200,000 for routine implementation in accredited laboratories
    Any requests for a higher level of funding should be discussed with WADA’s Science Department for which contact information is provided below.

    • Arxius

    Arxiu
    Call text